Education
About Us
Working with TipRanks
Follow Us
Shield Therapeutics PLC (GB:STX)
LSE:STX
STX Analyst Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
STX Stock 12 Month Forecast
Average Price Target
10.75p
▲(34.38% Upside)
| Highest Price Target15.00p | Average Price Target10.75p | Lowest Price Target6.50p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
5.5p→6.5p
Hold
-18.75%
Downside
Reiterated
08/19/25
AI Generated ArticleAI Generated Article
Stifel Nicolaus
3.5p→3.8p
Hold
-52.50%
Downside
Reiterated
02/19/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
5.5p→6.5p
Hold
-18.75%
Downside
Reiterated
08/19/25
AI Generated ArticleAI Generated Article
Stifel Nicolaus
3.5p→3.8p
Hold
-52.50%
Downside
Reiterated
02/19/25
Best Analysts Covering Shield Therapeutics
1 Month
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Unknown AnalystPeel Hunt
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a buy rating 8 days ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
STX Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
0
0
0
0
1
Buy
0
0
0
0
0
Hold
5
7
9
9
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
9
9
7
Each month's total comprises the sum of three months' worth of ratings.
STX Financial Forecast
STX Stock Forecast FAQ
What is GB:STX’s average 12-month price target, according to analysts?
Based on analyst ratings, Shield Therapeutics PLC’s 12-month average price target is 10.75.
What is GB:STX’s upside potential, based on the analysts’ average price target?
Shield Therapeutics PLC has 34.38% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Shield Therapeutics PLC a Buy, Sell or Hold?
Shield Therapeutics PLC has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Shield Therapeutics PLC’s share price target?
The average share price target for Shield Therapeutics PLC is 10.75. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 15.00p ,and the lowest forecast is 6.50p. The average share price target represents 34.38% Increase from the current price of 8p.
The highest analyst share price target is 15.00p ,and the lowest forecast is 6.50p. The average share price target represents 34.38% Increase from the current price of 8p.
What do analysts say about Shield Therapeutics PLC?
Shield Therapeutics PLC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Shield Therapeutics PLC?
To buy shares of GB:STX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.